J. Domagala-Kulawik (Warsaw, Poland), H. Popper (Graz, Austria)
Angiogenic squamous dysplasia: highly associated with squamous cell lung carcinoma
S. Karimi, F. Mohammadi, K. Khodadad, M. Bahadori (Tehran, Islamic Republic Of Iran)
|  |
The role of serum copper and zinc levels and copper/zinc ratio in lung cancer
S. S. Hacievliyagil, H. Gunen, L. C. Mutlu, G. Gülbas, O. Yetkin, H. Atmaca (Malatya, Turkey)
| |
Antioxidant and inflammatory status in lung cancer patients: systemic or local correlation?
K. Katsoulis, T. Kontakiotis, O. Chatzizisi, M. Kougioulis, S. Gerou, D. Papakosta (Thessaloniki, Greece)
| |
E-cadherin and beta-catenin expression in imprints of NSCLC. Relationship with prognostic parameters
E. Pagaki, P. Athanassiades, E. Patsouris, M. Gonidi, V. Dimitropoulou, P. Athanassiadou (Athens, Greece)
| |
The clinical significance of soluble E-cadherin in lung cancer
A. Gogali, C. Charalabopoulos, G. Dalavanga, M. Vassiliou, G. Daskalopoulos, S. Constantopoulos (Ioannina, Greece)
| |
Immunohistocemical expression of P53 and BCL-2 in pateints with lung cancer: correlation with survival time
C. S. Tsobanidou, E. A. Boutsikou, J. Angel, C. Tsairidis, G. Sarikos, T. Toliou (Thessaloniki, Alexandroupoli, Greece)
| |
Expression of βig-h3 as a marker of local tumor invasion in non-small cell lung cancer
S. B. Han, J. E. Lee, H. P. Park, Y. J. Jeon, J. Y. Park (Daegu, Republic Of Korea)
| |
Prognostic value of Her2/neu in stage IIIA non-small cell lung cancer
O. A. Sukhoversha, V. A. Kosse, V. V. Lizogubov (Dnipropetrovsk, Ukraine)
| |
Symptom distress of Taiwanese lung cancer patients and its relationship to cytokines
C. C. Lin, S. Y. Wang (Taipei, Taiwan, Province Of China)
| |
Analysis of surgical stage lung cancer and tumour markers prognostic value
A. Rego, A. Oliveira, A. Barroso, S. Conde, A. Lira, J. Miranda, F. Leal, B. Parente (Vila Nova de Gaia, Portugal)
| |
Changes of lung function in patients with non-small cell lung cancer tretaed by chemotherapy
S. Rancic, M. Rancic (Nis, Serbia And Montenegro)
| |
Lung function in lung cancer patients: correlation with smoking habit or other physiological variables?
A. Eslami, E. Albo, L. Scarcella, S. Baglioni, E. Scoscia, B. Lucio, T. Todisco (Perugia, Italy)
| |
Long-term outcome after surgery for bronchial carcinoid tumors
D. Petrov, E. Goranov, S. Danon, M. Plochev, T. Minchev (Sofia, Bulgaria)
| |
Comparison of the ²pre-treatment time interval² and ²diseases free interval² in surgically treated NSCLC patients
G. D. Radosavljevic-Asic, T. Adzic, D. Subotic (Belgrade, Serbia And Montenegro)
| |
Combined external beam irradiation and high dose-rate brachytherapy in tracheal cancers
S. S. Vucicevic, J. B. Stankovic, K. M. Dabic-Stankovic, N. P. Jovanovic, B. J. Lukac, E. S. Sudjic (Belgrade, Serbia And Montenegro)
| |
Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer (NSCLC). A phase II study
K. N. Syrigos, A. G. Charpidou, K. Dilana, G. Dionalis, A. Rigipoulou, N. Geogratou, C. Roussos (Athens, Greece)
| |
Combination of neoadjuvant and adjuvant chemotherapy in marginally resectable IIIA nonsmall cell lung cancer (NSCLC): long-term follow up
V. Kolek, I. Grygarkova, M. Hajduch, J. Klein, C. Neoral (Olomouc, Czech Republic)
| |
Single institution experience in advanced non-small cell lung cancer (NSCLC) patients (pts) with erlotinib (Tarceva®) within a large extended access programme* (EAP)
T. C. Gauler, M. Tewes, V. Sailer, S. Bildat, P. Schuett, S. Korfee, J. Stattaus, M. Toetsch, S. Seeber, W. Eberhardt (Essen, Germany)
| |
Biological characteristics of dendritic cells from malignant pleural effusions in patients with lung cancer
J. A. Huang, T. Z. Yan, Y. B. Zhu, Y. Huang, X. G. Zhang (Suzhou, China)
| |
Efficacy of doxycycline with small-bore catheters in patients with malignant pleural effusion
J. Signes-Costa, M. Llombart, E. Chiner, E. Pastor, A. L. Andreu, E. Gómez-Merino, C. Senent, A. Camarasa, J. M. Arriero, J. Marco (San Juan de Alicante, Spain)
| |